Skip to main content
Premium Trial:

Request an Annual Quote

New Horizon

The European Parliament has approved the Horizon 2020 funding scheme, ScienceInsider reports. Horizon 2020, first proposed in 2011, is the European Union's research and innovation initiative. With almost €80 billion over seven years in funding, the program aims to bolster research in the EU by, as a press release notes, focusing on the three "pillars" of good science, leadership in industry, and challenges facing society.

ScienceInsider notes that the European Commission originally proposed €80 billion in funding for Horizon 2020, and the European Parliament backed an increase to €100 billion, but "it faced resistance from money-conscious member states, which instead downsized the budget." Still, the current Horizon 2020 funding level is higher than its predecessor program, which was given €55 billion.

"This is a vote of confidence in the power of EU research and innovation funding. It paves the way for more investment in knowledge and competitiveness in Europe," Máire Geoghegan-Quinn, the European Commissioner for Research, Innovation, and Science, said in a statement after the vote.

Member states must next formally approve the program, and the first call for proposals is set to go out December 11.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.